Organoids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, Offering, Method, and Geography

Description

List of Tables

According to our new research study on "Organoids Market Forecast to 2031 -Global Analysis - by Type, Application, Source, and Geography," the market is anticipated to grow from US$ 3.03 billion in 2023 and is projected to reach US$ 15.01 billion by 2031; it is expected to register a CAGR of 22.1% during 2023-2031. Factors contributing to the organoids market growth include the rising demand for novel drug screening services, and an upsurge in the popularity of customized medications. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.

Organoids are simple tissue-engineered cell-based in vitro models that recapitulate many aspects of the complex structure and function of the corresponding in vivo tissue. They can be dissected and interrogated for fundamental mechanistic studies on development, regeneration and repair in human tissues, and can also be used in diagnostics, disease modelling, drug discovery and personalized medicine.

North America dominates the organoids market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. In February 2023, Molecular Devices, LLC. and HUB Organoids (HUB) announced a strategic collaboration to continue the development of next-generation 3D biology technologies that drive step-change reduction in preclinical to clinical drug attrition. Further, increasing research and development activities, rising demand for tissue engineering and organ transplantation, and a high rate of organoid adoption are driving the organoid services market in the country. Organoids have the potential to overcome several previous limitations associated with biomedical research studies, with a high focus on making mechanistic insights on human development available for researchers, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. Asia Pacific is anticipated to record the highest CAGR during 2023-2031.

Increasing Key Developments to Provide Market Opportunities in Future

The progress of the healthcare sector has led to a rise in the demand for organoids across the world. This increased demand contributes to new product developments, acquisitions, partnerships, product launches, and approvals on a global level. Major market players are involved in activities to ensure the innovation and development of efficient services and products. A few of the recent key developments are listed below:

In June 2024, Molecular Devices, LLC. formally opened its purpose-built facility in Cardiff, UK. The multimillion-pound facility was designed to accommodate the exclusive bioprocess workflow and innovative bioreactor technology of the business, allowing for the large-scale, quality-controlled production of PDOs. Substantial amounts of repeatable PDOs that are 3D-ready are available as a custom service and are cryopreserved in a manner that is ready for analysis. Researchers can defrost, plate, and use these products as needed.

In May 2024, InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research.

In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.

In February 2023, Molecular Devices, LLC., and HUB Organoids (HUB) announced a strategic collaboration to contribute to the continued development of next-generation 3D biology technologies that enable step-change reduction in preclinical to clinical drug attrition.

In December 2022, Molecular Devices, LLC. acquired Cellesce Ltd. This acquisition focuses on producing large-scale PDOs for various purposes, including drug screening, through contract development and production services.

In August 2021, STEMCELL Technologies and Hubrecht Organoid Technology (HUB) signed an agreement. As a part of this agreement, STEMCELL's Contract Assay Services division began providing its tissue-derived organoids, such as lung, intestinal, and liver organoids, for pre-clinical toxicology screening and non-cancer drug development services to HUB. These services would facilitate the integration of organoids into preclinical testing programs by researchers and drug development organizations to aid in the faster and more economical launch of new therapies.

Such key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid market growth..

Application -Based Insights

By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023-2031.

Source -Based Insights

Based on source, the organoids market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.

Organoids Market: Competitive Landscape and Key Developments

STEMCELL Technologies Inc, Molecular Devices, LLC., InSphero, Definigen, Organoid Therapeutics, Thermo Fisher Scientific Inc, Corning Inc, Merck KGaA, HUB Organoids B.V. (Hubrecht Organoid Technology) are among the key companies operating in the organoids market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the organoids market report.

Product Code: TIPRE00017616

1. Introduction

1.1 The Insight Partners Research Report Guidance.
1.2 Market Segmentation.

2. Executive Summary

2.1 Key Insights.

3. Research Methodology

3.1 Secondary Research.
3.2 Primary Research.
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Organoids Market Landscape

4.1 PEST Analysis.

5. Organoids Market - Key Market Dynamics

5.1 Organoids Market - Key Market Dynamics.
5.2 Market Drivers.
- 5.2.1 Increasing Demand for Tumor Modeling and Biobanking.
- 5.2.2 Surging Adoption of Personalized Drugs.
5.3 Market Restraints.
- 5.3.1 Dearth of Skilled Professionals.
5.4 Market Opportunities.
- 5.4.1 Focus on Drug Discovery Activities.
5.5 Future Trends.
- 5.5.1 Combination of Organoids and Organ-on-a-Chip.
5.6 Impact of Drivers and Restraints:

6. Organoids Market - Global Market Analysis

6.1 Organoids Market Revenue (US$ Million), 2021-2031.
6.2 Organoids Market Forecast Analysis.

7. Organoids Market Analysis - by Type

7.1 Intestine.
- 7.1.1 Overview.
- 7.1.2 Intestine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Liver
- 7.2.1 Overview.
- 7.2.2 Liver: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Stomach.
- 7.3.1 Overview.
- 7.3.2 Stomach: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Pancreas.
- 7.4.1 Overview.
- 7.4.2 Pancreas: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Lung.
- 7.5.1 Overview.
- 7.5.2 Lung: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Brain.
- 7.6.1 Overview.
- 7.6.2 Brain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
7.7 Kidney.
- 7.7.1 Overview.
- 7.7.2 Kidney: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
7.8 Others.
- 7.8.1 Overview.
- 7.8.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

8. Organoids Market Analysis - by Application

8.1 Developmental Biology Disease.
- 8.1.1 Overview.
- 8.1.2 Developmental Biology Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Pathology of Infectious Disease.
- 8.2.1 Overview.
- 8.2.2 Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regenerative Medicine.
- 8.3.1 Overview.
- 8.3.2 Regenerative Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Drug Toxicity and Efficacy Testing.
- 8.4.1 Overview
- 8.4.2 Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Drug Discovery and Personalized Medicine.
- 8.5.1 Overview.
- 8.5.2 Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others.
- 8.6.1 Overview.
- 8.6.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

9. Organoids Market Analysis - by Source

9.1 Pluripotent Stem Cells
- 9.1.1 Overview.
- 9.1.2 Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Organ-Specific Adult Stem Cell 70
- 9.2.1 Overview.
- 9.2.2 Organ-Specific Adult Stem Cell: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

10. Organoids Market Analysis - by Offering

10.1 Instruments.
- 10.1.1 Overview.
- 10.1.2 Instruments: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Consumables.
- 10.2.1 Overview.
- 10.2.2 Consumables: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Services.
- 10.3.1 Overview.
- 10.3.2 Services: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

11. Organoids Market Analysis - by Method

11.1 Micropatterned Plates.
- 11.1.1 Overview.
- 11.1.2 Micropatterned Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Ultralow Attachment Plates.
- 11.2.1 Overview.
- 11.2.2 Ultralow Attachment Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Hanging Drop.
- 11.3.1 Overview.
- 11.3.2 Hanging Drop: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Microdroplet or Emulsion.
- 11.4.1 Overview.
- 11.4.2 Microdroplet or Emulsion: Organoids Market - Revenue and Forecast to 2031 (US$ Million) 79
11.5 Others.
- 11.5.1 Overview.
- 11.5.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

12. Organoids Market - Geographical Analysis

12.1 Overview.
12.2 North America.
- 12.2.1 North America Organoids Market Overview.
- 12.2.2 North America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.3 North America: Organoids Market Breakdown, by Type.
  - 12.2.3.1 North America: Organoids Market - Revenue and Forecast Analysis - by Type.
- 12.2.4 North America: Organoids Market Breakdown, by Application.
  - 12.2.4.1 North America: Organoids Market - Revenue and Forecast Analysis - by Application.
- 12.2.5 North America: Organoids Market Breakdown, by Source.
  - 12.2.5.1 North America: Organoids Market - Revenue and Forecast Analysis - by Source.
- 12.2.6 North America: Organoids Market Breakdown, by Offering.
  - 12.2.6.1 North America: Organoids Market - Revenue and Forecast Analysis - by Offering.
- 12.2.7 North America: Organoids Market Breakdown, by Instruments.
  - 12.2.7.1 North America: Organoids Market - Revenue and Forecast Analysis - by Instruments.
- 12.2.8 North America: Organoids Market Breakdown, by Consumables.
  - 12.2.8.1 North America: Organoids Market - Revenue and Forecast Analysis - by Consumables.
- 12.2.9 North America: Organoids Market Breakdown, by Method.
  - 12.2.9.1 North America: Organoids Market - Revenue and Forecast Analysis - by Method.
- 12.2.10 North America: Organoids Market - Revenue and Forecast Analysis - by Country.
  - 12.2.10.1 North America: Organoids Market - Revenue and Forecast Analysis - by Country.
  - 12.2.10.2 United States: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.10.2.1 United States: Organoids Market Breakdown, by Type.
    - 12.2.10.2.2 United States: Organoids Market Breakdown, by Application.
    - 12.2.10.2.3 United States: Organoids Market Breakdown, by Source.
    - 12.2.10.2.4 United States: Organoids Market Breakdown, by Offering.
    - 12.2.10.2.5 United States: Organoids Market Breakdown, by Instruments.
    - 12.2.10.2.6 United States: Organoids Market Breakdown, by Consumables.
    - 12.2.10.2.7 United States: Organoids Market Breakdown, by Method.
  - 12.2.10.3 Canada: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.10.3.1 Canada: Organoids Market Breakdown, by Type.
    - 12.2.10.3.2 Canada: Organoids Market Breakdown, by Application.
    - 12.2.10.3.3 Canada: Organoids Market Breakdown, by Source.
    - 12.2.10.3.4 Canada: Organoids Market Breakdown, by Offering.
    - 12.2.10.3.5 Canada: Organoids Market Breakdown, by Instruments.
    - 12.2.10.3.6 Canada: Organoids Market Breakdown, by Consumables.
    - 12.2.10.3.7 Canada: Organoids Market Breakdown, by Method.
  - 12.2.10.4 Mexico: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.10.4.1 Mexico: Organoids Market Breakdown, by Type.
    - 12.2.10.4.2 Mexico: Organoids Market Breakdown, by Application.
    - 12.2.10.4.3 Mexico: Organoids Market Breakdown, by Source.
    - 12.2.10.4.4 Mexico: Organoids Market Breakdown, by Offering.
    - 12.2.10.4.5 Mexico: Organoids Market Breakdown, by Instruments.
    - 12.2.10.4.6 Mexico: Organoids Market Breakdown, by Consumables.
    - 12.2.10.4.7 Mexico: Organoids Market Breakdown, by Method.
12.3 Europe.
- 12.3.1 Europe Organoids Market Overview.
- 12.3.2 Europe: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.3 Europe: Organoids Market Breakdown, by Type.
  - 12.3.3.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Type.
- 12.3.4 Europe: Organoids Market Breakdown, by Application.
  - 12.3.4.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Application.
- 12.3.5 Europe: Organoids Market Breakdown, by Source.
  - 12.3.5.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Source.
- 12.3.6 Europe: Organoids Market Breakdown, by Offering.
  - 12.3.6.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Offering.
- 12.3.7 Europe: Organoids Market Breakdown, by Instruments.
  - 12.3.7.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Instruments.
- 12.3.8 Europe: Organoids Market Breakdown, by Consumables.
  - 12.3.8.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Consumables.
- 12.3.9 Europe: Organoids Market Breakdown, by Method.
  - 12.3.9.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Method.
- 12.3.10 Europe: Organoids Market - Revenue and Forecast Analysis - by Country.
  - 12.3.10.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Country.
  - 12.3.10.2 Germany: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.10.2.1 Germany: Organoids Market Breakdown, by Type.
    - 12.3.10.2.2 Germany: Organoids Market Breakdown, by Application.
    - 12.3.10.2.3 Germany: Organoids Market Breakdown, by Source.
    - 12.3.10.2.4 Germany: Organoids Market Breakdown, by Offering.
    - 12.3.10.2.5 Germany: Organoids Market Breakdown, by Instruments.
    - 12.3.10.2.6 Germany: Organoids Market Breakdown, by Consumables.
    - 12.3.10.2.7 Germany: Organoids Market Breakdown, by Method.
  - 12.3.10.3 France: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.10.3.1 France: Organoids Market Breakdown, by Type.
    - 12.3.10.3.2 France: Organoids Market Breakdown, by Application.
    - 12.3.10.3.3 France: Organoids Market Breakdown, by Source.
    - 12.3.10.3.4 France: Organoids Market Breakdown, by Offering.
    - 12.3.10.3.5 France: Organoids Market Breakdown, by Instruments.
    - 12.3.10.3.6 France: Organoids Market Breakdown, by Consumables.
    - 12.3.10.3.7 France: Organoids Market Breakdown, by Method.
  - 12.3.10.4 United Kingdom: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.10.4.1 United Kingdom: Organoids Market Breakdown, by Type.
    - 12.3.10.4.2 United Kingdom: Organoids Market Breakdown, by Application.
    - 12.3.10.4.3 United Kingdom: Organoids Market Breakdown, by Source.
    - 12.3.10.4.4 United Kingdom: Organoids Market Breakdown, by Offering.
    - 12.3.10.4.5 United Kingdom: Organoids Market Breakdown, by Instruments.
    - 12.3.10.4.6 United Kingdom: Organoids Market Breakdown, by Consumables.
    - 12.3.10.4.7 United Kingdom: Organoids Market Breakdown, by Method.
  - 12.3.10.5 Italy: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.10.5.1 Italy: Organoids Market Breakdown, by Type.
    - 12.3.10.5.2 Italy: Organoids Market Breakdown, by Application.
    - 12.3.10.5.3 Italy: Organoids Market Breakdown, by Source.
    - 12.3.10.5.4 Italy: Organoids Market Breakdown, by Offering.
    - 12.3.10.5.5 Italy: Organoids Market Breakdown, by Instruments.
    - 12.3.10.5.6 Italy: Organoids Market Breakdown, by Consumables.
    - 12.3.10.5.7 Italy: Organoids Market Breakdown, by Method.
  - 12.3.10.6 Spain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.10.6.1 Spain: Organoids Market Breakdown, by Type.
    - 12.3.10.6.2 Spain: Organoids Market Breakdown, by Application.
    - 12.3.10.6.3 Spain: Organoids Market Breakdown, by Source.
    - 12.3.10.6.4 Spain: Organoids Market Breakdown, by Offering.
    - 12.3.10.6.5 Spain: Organoids Market Breakdown, by Instruments.
    - 12.3.10.6.6 Spain: Organoids Market Breakdown, by Consumables.
    - 12.3.10.6.7 Spain: Organoids Market Breakdown, by Method.
  - 12.3.10.7 Rest of Europe: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.10.7.1 Rest of Europe: Organoids Market Breakdown, by Type.
    - 12.3.10.7.2 Rest of Europe: Organoids Market Breakdown, by Application.
    - 12.3.10.7.3 Rest of Europe: Organoids Market Breakdown, by Source.
    - 12.3.10.7.4 Rest of Europe: Organoids Market Breakdown, by Offering.
    - 12.3.10.7.5 Rest of Europe: Organoids Market Breakdown, by Instruments.
    - 12.3.10.7.6 Rest of Europe: Organoids Market Breakdown, by Consumables.
    - 12.3.10.7.7 Rest of Europe: Organoids Market Breakdown, by Method.
12.4 Asia Pacific.
- 12.4.1 Asia Pacific Organoids Market Overview.
- 12.4.2 Asia Pacific: Organoids Market - Revenue and Forecast to 2031 (US$ Million) 13
- 12.4.3 Asia Pacific: Organoids Market Breakdown, by Type.
  - 12.4.3.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Type.
- 12.4.4 Asia Pacific: Organoids Market Breakdown, by Application.
  - 12.4.4.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Application.
- 12.4.5 Asia Pacific: Organoids Market Breakdown, by Source.
  - 12.4.5.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Source.
- 12.4.6 Asia Pacific: Organoids Market Breakdown, by Offering.
  - 12.4.6.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Offering.
- 12.4.7 Asia Pacific: Organoids Market Breakdown, by Instruments.
  - 12.4.7.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Instruments.
- 12.4.8 Asia Pacific: Organoids Market Breakdown, by Consumables.
  - 12.4.8.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Consumables.
- 12.4.9 Asia Pacific: Organoids Market Breakdown, by Method.
  - 12.4.9.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Method.
- 12.4.10 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Country.
  - 12.4.10.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Country.
  - 12.4.10.2 Japan: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.2.1 Japan: Organoids Market Breakdown, by Type.
    - 12.4.10.2.2 Japan: Organoids Market Breakdown, by Application.
    - 12.4.10.2.3 Japan: Organoids Market Breakdown, by Source.
    - 12.4.10.2.4 Japan: Organoids Market Breakdown, by Offering
    - 12.4.10.2.5 Japan: Organoids Market Breakdown, by Instruments.
    - 12.4.10.2.6 Japan: Organoids Market Breakdown, by Consumables.
    - 12.4.10.2.7 Japan: Organoids Market Breakdown, by Method.
  - 12.4.10.3 China: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.3.1 China: Organoids Market Breakdown, by Type.
    - 12.4.10.3.2 China: Organoids Market Breakdown, by Application.
    - 12.4.10.3.3 China: Organoids Market Breakdown, by Source.
    - 12.4.10.3.4 China: Organoids Market Breakdown, by Offering.
    - 12.4.10.3.5 China: Organoids Market Breakdown, by Instruments.
    - 12.4.10.3.6 China: Organoids Market Breakdown, by Consumables.
    - 12.4.10.3.7 China: Organoids Market Breakdown, by Method.
  - 12.4.10.4 India: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.4.1 India: Organoids Market Breakdown, by Type.
    - 12.4.10.4.2 India: Organoids Market Breakdown, by Application
    - 12.4.10.4.3 India: Organoids Market Breakdown, by Source.
    - 12.4.10.4.4 India: Organoids Market Breakdown, by Offering
    - 12.4.10.4.5 India: Organoids Market Breakdown, by Instruments.
    - 12.4.10.4.6 India: Organoids Market Breakdown, by Consumables.
    - 12.4.10.4.7 India: Organoids Market Breakdown, by Method.
  - 12.4.10.5 South Korea: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.5.1 South Korea: Organoids Market Breakdown, by Type.
    - 12.4.10.5.2 South Korea: Organoids Market Breakdown, by Application.
    - 12.4.10.5.3 South Korea: Organoids Market Breakdown, by Source.
    - 12.4.10.5.4 South Korea: Organoids Market Breakdown, by Offering.
    - 12.4.10.5.5 South Korea: Organoids Market Breakdown, by Instruments.
    - 12.4.10.5.6 South Korea: Organoids Market Breakdown, by Consumables.
    - 12.4.10.5.7 South Korea: Organoids Market Breakdown, by Method.
  - 12.4.10.6 Australia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.6.1 Australia: Organoids Market Breakdown, by Type.
    - 12.4.10.6.2 Australia: Organoids Market Breakdown, by Application.
    - 12.4.10.6.3 Australia: Organoids Market Breakdown, by Source.
    - 12.4.10.6.4 Australia: Organoids Market Breakdown, by Offering.
    - 12.4.10.6.5 Australia: Organoids Market Breakdown, by Instruments.
    - 12.4.10.6.6 Australia: Organoids Market Breakdown, by Consumables.
    - 12.4.10.6.7 Australia: Organoids Market Breakdown, by Method.
  - 12.4.10.7 Singapore: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.7.1 Singapore: Organoids Market Breakdown, by Type.
    - 12.4.10.7.2 Singapore: Organoids Market Breakdown, by Application.
    - 12.4.10.7.3 Singapore: Organoids Market Breakdown, by Source.
    - 12.4.10.7.4 Singapore: Organoids Market Breakdown, by Offering.
    - 12.4.10.7.5 Singapore: Organoids Market Breakdown, by Instruments.
    - 12.4.10.7.6 Singapore: Organoids Market Breakdown, by Consumables.
    - 12.4.10.7.7 Singapore: Organoids Market Breakdown, by Method.
  - 12.4.10.8 Thailand: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.8.1 Thailand: Organoids Market Breakdown, by Type.
    - 12.4.10.8.2 Thailand: Organoids Market Breakdown, by Application.
    - 12.4.10.8.3 Thailand: Organoids Market Breakdown, by Source.
    - 12.4.10.8.4 Thailand: Organoids Market Breakdown, by Offering.
    - 12.4.10.8.5 Thailand: Organoids Market Breakdown, by Instruments.
    - 12.4.10.8.6 Thailand: Organoids Market Breakdown, by Consumables.
    - 12.4.10.8.7 Thailand: Organoids Market Breakdown, by Method.
  - 12.4.10.9 Malaysia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.9.1 Malaysia: Organoids Market Breakdown, by Type.
    - 12.4.10.9.2 Malaysia: Organoids Market Breakdown, by Application.
    - 12.4.10.9.3 Malaysia: Organoids Market Breakdown, by Source.
    - 12.4.10.9.4 Malaysia: Organoids Market Breakdown, by Offering.
    - 12.4.10.9.5 Malaysia: Organoids Market Breakdown, by Instruments.
    - 12.4.10.9.6 Malaysia: Organoids Market Breakdown, by Consumables.
    - 12.4.10.9.7 Malaysia: Organoids Market Breakdown, by Method.
  - 12.4.10.10 Vietnam: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.10.1 Vietnam: Organoids Market Breakdown, by Type.
    - 12.4.10.10.2 Vietnam: Organoids Market Breakdown, by Application.
    - 12.4.10.10.3 Vietnam: Organoids Market Breakdown, by Source.
    - 12.4.10.10.4 Vietnam: Organoids Market Breakdown, by Offering.
    - 12.4.10.10.5 Vietnam: Organoids Market Breakdown, by Instruments.
    - 12.4.10.10.6 Vietnam: Organoids Market Breakdown, by Consumables.
    - 12.4.10.10.7 Vietnam: Organoids Market Breakdown, by Method.
  - 12.4.10.11 Indonesia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.11.1 Indonesia: Organoids Market Breakdown, by Type.
    - 12.4.10.11.2 Indonesia: Organoids Market Breakdown, by Application.
    - 12.4.10.11.3 Indonesia: Organoids Market Breakdown, by Source.
    - 12.4.10.11.4 Indonesia: Organoids Market Breakdown, by Offering.
    - 12.4.10.11.5 Indonesia: Organoids Market Breakdown, by Instruments.
    - 12.4.10.11.6 Indonesia: Organoids Market Breakdown, by Consumables.
    - 12.4.10.11.7 Indonesia: Organoids Market Breakdown, by Method.
  - 12.4.10.12 Philippines: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.12.1 Philippines: Organoids Market Breakdown, by Type.
    - 12.4.10.12.2 Philippines: Organoids Market Breakdown, by Application.
    - 12.4.10.12.3 Philippines: Organoids Market Breakdown, by Source.
    - 12.4.10.12.4 Philippines: Organoids Market Breakdown, by Offering.
    - 12.4.10.12.5 Philippines: Organoids Market Breakdown, by Instruments.
    - 12.4.10.12.6 Philippines: Organoids Market Breakdown, by Consumables.
    - 12.4.10.12.7 Philippines: Organoids Market Breakdown, by Method.
  - 12.4.10.13 Rest of APAC: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.10.13.1 Rest of APAC: Organoids Market Breakdown, by Type.
    - 12.4.10.13.2 Rest of APAC: Organoids Market Breakdown, by Application.
    - 12.4.10.13.3 Rest of APAC: Organoids Market Breakdown, by Source.
    - 12.4.10.13.4 Rest of APAC: Organoids Market Breakdown, by Offering.
    - 12.4.10.13.5 Rest of APAC: Organoids Market Breakdown, by Instruments.
    - 12.4.10.13.6 Rest of APAC: Organoids Market Breakdown, by Consumables.
    - 12.4.10.13.7 Rest of APAC: Organoids Market Breakdown, by Method.
12.5 Middle East and Africa.
- 12.5.1 Middle East and Africa Organoids Market Overview.
- 12.5.2 Middle East and Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.3 Middle East and Africa: Organoids Market Breakdown, by Type.
  - 12.5.3.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Type.
- 12.5.4 Middle East and Africa: Organoids Market Breakdown, by Application.
  - 12.5.4.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Application.
- 12.5.5 Middle East and Africa: Organoids Market Breakdown, by Source.
  - 12.5.5.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Source.
- 12.5.6 Middle East and Africa: Organoids Market Breakdown, by Offering.
  - 12.5.6.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Offering.
- 12.5.7 Middle East and Africa: Organoids Market Breakdown, by Instruments.
  - 12.5.7.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Instruments.
- 12.5.8 Middle East and Africa: Organoids Market Breakdown, by Consumables.
  - 12.5.8.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Consumables.
- 12.5.9 Middle East and Africa: Organoids Market Breakdown, by Method.
  - 12.5.9.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Method.
- 12.5.10 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Country.
  - 12.5.10.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Country.
  - 12.5.10.2 Saudi Arabia: Organoids Market - Revenue and Forecast to 2031 (US$ Million
    - 12.5.10.2.1 Saudi Arabia: Organoids Market Breakdown, by Type.
    - 12.5.10.2.2 Saudi Arabia: Organoids Market Breakdown, by Application.
    - 12.5.10.2.3 Saudi Arabia: Organoids Market Breakdown, by Source.
    - 12.5.10.2.4 Saudi Arabia: Organoids Market Breakdown, by Offering.
    - 12.5.10.2.5 Saudi Arabia: Organoids Market Breakdown, by Instruments.
    - 12.5.10.2.6 Saudi Arabia: Organoids Market Breakdown, by Consumables.
    - 12.5.10.2.7 Saudi Arabia: Organoids Market Breakdown, by Method.
  - 12.5.10.3 South Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.10.3.1 South Africa: Organoids Market Breakdown, by Type.
    - 12.5.10.3.2 South Africa: Organoids Market Breakdown, by Application.
    - 12.5.10.3.3 South Africa: Organoids Market Breakdown, by Source.
    - 12.5.10.3.4 South Africa: Organoids Market Breakdown, by Offering.
    - 12.5.10.3.5 South Africa: Organoids Market Breakdown, by Instruments.
    - 12.5.10.3.6 South Africa: Organoids Market Breakdown, by Consumables.
    - 12.5.10.3.7 South Africa: Organoids Market Breakdown, by Method.
  - 12.5.10.4 United Arab Emirates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.10.4.1 United Arab Emirates: Organoids Market Breakdown, by Type.
    - 12.5.10.4.2 United Arab Emirates: Organoids Market Breakdown, by Application.
    - 12.5.10.4.3 United Arab Emirates: Organoids Market Breakdown, by Source.
    - 12.5.10.4.4 United Arab Emirates: Organoids Market Breakdown, by Offering.
    - 12.5.10.4.5 United Arab Emirates: Organoids Market Breakdown, by Instruments.
    - 12.5.10.4.6 United Arab Emirates: Organoids Market Breakdown, by Consumables.
    - 12.5.10.4.7 United Arab Emirates: Organoids Market Breakdown, by Method.
  - 12.5.10.5 Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.10.5.1 Rest of Middle East and Africa: Organoids Market Breakdown, by Type.
    - 12.5.10.5.2 Rest of Middle East and Africa: Organoids Market Breakdown, by Application.
    - 12.5.10.5.3 Rest of Middle East and Africa: Organoids Market Breakdown, by Source.
    - 12.5.10.5.4 Rest of Middle East and Africa: Organoids Market Breakdown, by Offering.
    - 12.5.10.5.5 Rest of Middle East and Africa: Organoids Market Breakdown, by Instruments.
    - 12.5.10.5.6 Rest of Middle East and Africa: Organoids Market Breakdown, by Consumables.
    - 12.5.10.5.7 Rest of Middle East and Africa: Organoids Market Breakdown, by Method.
12.6 South and Central America.
- 12.6.1 South and Central America Organoids Market Overview.
- 12.6.2 South and Central America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.3 South and Central America: Organoids Market Breakdown, by Type.
  - 12.6.3.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Type.
- 12.6.4 South and Central America: Organoids Market Breakdown, by Application.
  - 12.6.4.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Application.
- 12.6.5 South and Central America: Organoids Market Breakdown, by Source.
  - 12.6.5.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Source.
- 12.6.6 South and Central America: Organoids Market Breakdown, by Offering.
  - 12.6.6.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Offering.
- 12.6.7 South and Central America: Organoids Market Breakdown, by Instruments.
  - 12.6.7.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Instruments.
- 12.6.8 South and Central America: Organoids Market Breakdown, by Consumables.
  - 12.6.8.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Consumables.
- 12.6.9 South and Central America: Organoids Market Breakdown, by Method.
  - 12.6.9.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Method.
- 12.6.10 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Country.
  - 12.6.10.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Country.
  - 12.6.10.2 Brazil: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.6.10.2.1 Brazil: Organoids Market Breakdown, by Type.
    - 12.6.10.2.2 Brazil: Organoids Market Breakdown, by Application.
    - 12.6.10.2.3 Brazil: Organoids Market Breakdown, by Source.
    - 12.6.10.2.4 Brazil: Organoids Market Breakdown, by Offering.
    - 12.6.10.2.5 Brazil: Organoids Market Breakdown, by Instruments.
    - 12.6.10.2.6 Brazil: Organoids Market Breakdown, by Consumables.
    - 12.6.10.2.7 Brazil: Organoids Market Breakdown, by Method.
  - 12.6.10.3 Argentina: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.6.10.3.1 Argentina: Organoids Market Breakdown, by Type.
    - 12.6.10.3.2 Argentina: Organoids Market Breakdown, by Application.
    - 12.6.10.3.3 Argentina: Organoids Market Breakdown, by Source.
    - 12.6.10.3.4 Argentina: Organoids Market Breakdown, by Offering.
    - 12.6.10.3.5 Argentina: Organoids Market Breakdown, by Instruments.
    - 12.6.10.3.6 Argentina: Organoids Market Breakdown, by Consumables.
    - 12.6.10.3.7 Argentina: Organoids Market Breakdown, by Method.
  - 12.6.10.4 Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.6.10.4.1 Rest of South and Central America: Organoids Market Breakdown, by Type.
    - 12.6.10.4.2 Rest of South and Central America: Organoids Market Breakdown, by Application.
    - 12.6.10.4.3 Rest of South and Central America: Organoids Market Breakdown, by Source.
    - 12.6.10.4.4 Rest of South and Central America: Organoids Market Breakdown, by Offering.
    - 12.6.10.4.5 Rest of South and Central America: Organoids Market Breakdown, by Instruments.
    - 12.6.10.4.6 Rest of South and Central America: Organoids Market Breakdown, by Consumables.
    - 12.6.10.4.7 Rest of South and Central America: Organoids Market Breakdown, by Method.

13. Industry Landscape

13.1 Overview.
13.2 Growth Strategies in Organoids Market
13.3 Organic Growth Strategies.
- 13.3.1 Overview.
13.4 Inorganic Growth Strategies.
- 13.4.1 Overview.

14. Company Profiles

14.1 STEMCELL Technologies Inc.
- 14.1.1 Key Facts.
- 14.1.2 Business Description.
- 14.1.3 Products and Services.
- 14.1.4 Financial Overview.
- 14.1.5 SWOT Analysis.
- 14.1.6 Key Developments.
14.2 Molecular Devices, LLC.
- 14.2.1 Key Facts.
- 14.2.2 Business Description.
- 14.2.3 Products and Services.
- 14.2.4 Financial Overview.
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments.
14.3 Hubrecht Organoid Technology.
- 14.3.1 Key Facts.
- 14.3.2 Business Description.
- 14.3.3 Products and Services.
- 14.3.4 Financial Overview.
- 14.3.5 SWOT Analysis.
- 14.3.6 Key Developments.
14.4 Definigen.
- 14.4.1 Key Facts.
- 14.4.2 Business Description.
- 14.4.3 Products and Services.
- 14.4.4 Financial Overview.
- 14.4.5 SWOT Analysis.
- 14.4.6 Key Developments.
14.5 Organoid Therapeutics.
- 14.5.1 Key Facts.
- 14.5.2 Business Description.
- 14.5.3 Products and Services.
- 14.5.4 Financial Overview.
- 14.5.5 SWOT Analysis.
- 14.5.6 Key Developments.
14.6 Thermo Fisher Scientific Inc.
- 14.6.1 Key Facts.
- 14.6.2 Business Description.
- 14.6.3 Products and Services.
- 14.6.4 Financial Overview.
- 14.6.5 SWOT Analysis.
- 14.6.6 Key Developments.
14.7 Corning Inc.
- 14.7.1 Key Facts.
- 14.7.2 Business Description.
- 14.7.3 Products and Services.
- 14.7.4 Financial Overview.
- 14.7.5 SWOT Analysis.
- 14.7.6 Key Developments.
14.8 Merck KGaA.
- 14.8.1 Key Facts.
- 14.8.2 Business Description.
- 14.8.3 Products and Services.
- 14.8.4 Financial Overview.
- 14.8.5 SWOT Analysis.
- 14.8.6 Key Developments.
14.9 InSphero.
- 14.9.1 Key Facts.
- 14.9.2 Business Description.
- 14.9.3 Products and Services.
- 14.9.4 Financial Overview.
- 14.9.5 SWOT Analysis.
- 14.9.6 Key Developments.
14.10 ACRO Biosystems.
- 14.10.1 Key Facts.
- 14.10.2 Business Description.
- 14.10.3 Products and Services.
- 14.10.4 Financial Overview.
- 14.10.5 SWOT Analysis.
- 14.10.6 Key Developments.
14.11 Bio-Techne Corp.
- 14.11.1 Key Facts.
- 14.11.2 Business Description.
- 14.11.3 Products and Services.
- 14.11.4 Financial Overview.
- 14.11.5 SWOT Analysis.
- 14.11.6 Key Developments.
14.12 SUN bioscience SA.
- 14.12.1 Key Facts.
- 14.12.2 Business Description.
- 14.12.3 Products and Services.
- 14.12.4 Financial Overview.
- 14.12.5 SWOT Analysis.
- 14.12.6 Key Developments.
14.13 ORGANOID SCIENCES Co., Ltd.
- 14.13.1 Key Facts.
- 14.13.2 Business Description.
- 14.13.3 Products and Services.
- 14.13.4 Financial Overview.
- 14.13.5 SWOT Analysis.
- 14.13.6 Key Developments.
14.14 Crown Bioscience Inc.
- 14.14.1 Key Facts.
- 14.14.2 Business Description.
- 14.14.3 Products and Services.
- 14.14.4 Financial Overview.
- 14.14.5 SWOT Analysis.
- 14.14.6 Key Developments.
14.15 Sartorius AG.
- 14.15.1 Key Facts.
- 14.15.2 Business Description.
- 14.15.3 Products and Services.
- 14.15.4 Financial Overview.
- 14.15.5 SWOT Analysis.
- 14.15.6 Key Developments.
14.16 3D Biotek LLC.
- 14.16.1 Key Facts.
- 14.16.2 Business Description.
- 14.16.3 Products and Services.
- 14.16.4 Financial Overview.
- 14.16.5 SWOT Analysis.
- 14.16.6 Key Developments.
14.17 Prellis Biologics Inc.
- 14.17.1 Key Facts.
- 14.17.2 Business Description.
- 14.17.3 Products and Services.
- 14.17.4 Financial Overview.
- 14.17.5 SWOT Analysis.
- 14.17.6 Key Developments.
14.18 3Dnamics Inc.
- 14.18.1 Key Facts.
- 14.18.2 Business Description.
- 14.18.3 Products and Services.
- 14.18.4 Financial Overview.
- 14.18.5 SWOT Analysis.
- 14.18.6 Key Developments.
14.19 Cellesce Ltd.
- 14.19.1 Key Facts.
- 14.19.2 Business Description.
- 14.19.3 Products and Services.
- 14.19.4 Financial Overview.
- 14.19.5 SWOT Analysis.
- 14.19.6 Key Developments.

15. Appendix

15.1 About The Insight Partners.